Product Information
CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0171 per EA under NDC 43547040010. Its NADAC has been published 488 times since May 31, 2017.
FDA first approved this application on Feb 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547040010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077797FDA Approved
2/28/2007
TE Code
AB
On Market Since
3/30/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 488 times since May 31, 2017, and over the history we have for it it has declined 31.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0171 per EA |
|---|---|
| All-time high | $0.0275 (Dec 16, 2020) |
| All-time low | $0.0144 (Nov 20, 2024) |
| 52-week high | $0.0190 |
| 52-week low | $0.0169 |
| Median price | $0.0232 |
| Average price | $0.0223 |
| Largest weekly change | +32.5% (Jun 19, 2024) |
| Weeks tracked | 488 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
cyclobenzaprine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Muscle Relaxant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0171 per EA (NDC 43547040010), effective Sep 30, 2026.
How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has declined 31.1%. It has been tracked across 488 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?
Since May 31, 2017, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0144 (Nov 20, 2024) to a high of $0.0275 (Dec 16, 2020), with a median of $0.0232 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 10 MG TABLET?
CYCLOBENZAPRINE 10 MG TABLET (NDC 43547040010) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.